$EBS

$6.48▲ +0.3% YTD

6 SEC 13D/G filings tracked · Last updated Sep 3, 2026

Filing History

News

EBS ▲ +0.3% - Emergent BioSolutions Inc.

CP $6.48▲ +0.3%Sep 3, 2026 · ThinkSabio Blog

$EBS - Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes…

News

EBS ▲ +4.8% - Emergent BioSolutions Inc.

CP $6.39▲ +4.8%Sep 1, 2026 · ThinkSabio Blog

$EBS - Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)…

News

EBS ▼ -2.9% - Emergent BioSolutions Inc.

CP $5.75▲ -2.9%Aug 31, 2026 · ThinkSabio Blog

$EBS - Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray…

News

EBS ▼ -2.9% - Emergent BioSolutions Inc.

CP $5.75▲ -2.9%Aug 31, 2026 · ThinkSabio Blog

$EBS - Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day…

SEC 13D/G

$EBS SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks Simplified

$7.12▼ -43.13%Jul 31, 2026 · ThinkSabio Blog

$EBS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #EBS : $7.12 Sector: Healthcare | YTD: 🔽 -43.13% The SEC disclose…

SEC 13D/G

$EBS SEC Filing Update (28-JUL-2026) | ThinkSabio - Stocks Simplified

$7.31▼ -41.61%Jul 28, 2026 · ThinkSabio Blog

$EBS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #EBS : $7.31 Sector: Healthcare | YTD: 🔽 -41.61% The SEC disclose…